Group 1: Company Position and Achievements - The company has established a leading market position in the malt industry, with an annual production capacity of 1.08 million tons, ranking first in Asia and fourth globally [1] - Key factors contributing to this success include a focus on core business, high-end positioning, demand-driven capacity optimization, continuous innovation, supply chain improvement, and unified management [1] Group 2: Challenges Faced - The company faces challenges in adapting to changing customer and market demands, requiring timely adjustments to production strategies [1] - Technological advancements necessitate automation, digitalization, and intelligent transformation in traditional manufacturing processes [1] - Increasing environmental pressures due to national carbon neutrality goals, with the company aiming to enhance the use of clean energy [1] Group 3: Future Plans and Goals - The company aims to become a world-class malt supplier, focusing on providing high-quality malt and professional services to brewers [2] - Plans include deepening reforms, strengthening innovation, enhancing core functions, and improving operational efficiency for balanced growth [2] Group 4: Risk Management - The company manages bad debt risk by implementing a credit rating system for clients, offering credit terms primarily to reputable large beer groups while requiring cash transactions from new or retail clients [2] - There have been no occurrences of bad debts in recent years [2]

Group 1: Financial Performance and Risks - The company emphasizes the importance of receivables collection and sales revenue recognition in the photovoltaic industry, facing challenges such as project delays and potential bad debts [1] - Most of the unrecognized sales in the photovoltaic sector have been prepaid, effectively mitigating financial risks [2] - In 2024, the company has made provisions for inventory impairment related to high-risk clients, maintaining overall financial risk within a controllable range [2] Group 2: Controlled Nuclear Fusion Business - The controlled nuclear fusion business is part of the company's research institute segment, with long-term collaborations with various research institutions, including nearly 20 years with 585 Institute [3] - The company provides power support for most domestic nuclear fusion projects, collaborating with entities like the Chinese Academy of Sciences and New Energy Group [3] - The power supply for nuclear fusion devices typically exceeds megawatt levels, including magnetic field power supplies, heating power supplies, and control system power supplies, with cumulative revenue in this sector reaching several million yuan [4] Group 3: Competitive Landscape - The nuclear fusion power supply sector has high technical barriers due to specific operational requirements, resulting in few domestic competitors capable of research and production [5] - Major competitors in project bidding come from cities like Tianjin, Wuhan, Chengdu, and Anshan [5] Group 4: Semiconductor and Charging Pile Business - In 2024, the semiconductor business revenue reached 350 million yuan, with expectations for year-on-year growth based on increasing orders in the second quarter [7] - The company is collaborating with leading domestic firms on new charging pile products, which are currently in the validation stage, potentially leading to significant revenue growth in 2025 [7]

Group 1: Investor Relations Activity - The company participated in a broker strategy meeting in Chengdu with 17 investors from various institutions [2] - The meeting was hosted by the Securities Department Manager, Li Tanhang [2] Group 2: Sales and Market Performance - In 2024, the company's overseas feed sales reached 2.36 million tons, a year-on-year increase of approximately 40%, accounting for about 10% of total feed exports [2][4] - The company aims to achieve a short-term target of 3 million tons in feed sales by 2025, with cumulative external sales exceeding 2 million tons to date [4] Group 3: Industry Insights - The poultry inventory remains stable, while pig prices are consistently above cost, with an increase in inventory [3] - Most special fish species have seen price increases year-on-year, with some at historical highs; common fish have stabilized after a loss period [3] Group 4: Future Development Plans - The company plans to accelerate overseas feed business expansion, targeting 7.2 million tons in sales by 2030, focusing on Southeast Asia, Africa, and South America [5] - In Southeast Asia, Vietnam is the core market, with expansions planned in Indonesia, Bangladesh, and Malaysia; in Africa, Egypt serves as a hub for further market penetration [5] Group 5: Research and Development - The company has a research team of nearly 4,000 people, with cumulative R&D investment exceeding 5 billion yuan [7] - A comprehensive three-tier R&D system supports the company's rapid development, with a large database for animal nutrition needs and raw material formulation technology [7][8] Group 6: Competitive Landscape - The pig feed market has seen significant changes, with competition easing compared to the previous year, but remains intense overall [8] Group 7: Capital Expenditure - Capital expenditure will focus on overseas markets, while domestic spending will prioritize upgrading and renovating existing capacities [8]

Financial Performance - In 2024, the company achieved total revenue of 2,193.99 million CNY, a growth of 1.03% compared to 2023's 2,171.60 million CNY [1] - The total profit reached 643.94 million CNY, marking a 24.24% increase from 518.28 million CNY in the previous year [1] - Net profit attributable to shareholders was 521.53 million CNY, up 23.79% from 421.30 million CNY year-on-year [1] - In Q1 2025, the net profit excluding non-recurring gains and losses was 97.67 million CNY, an 11.61% increase from 87.52 million CNY in Q1 2024 [1] Biopharmaceutical Development - The biopharmaceutical sector is a key component of the company's dual strategy, facing a challenging environment with long R&D cycles and high investment risks [1] - The company has seen significant growth in business development and customer resource accumulation in 2023, although it still falls short of scale production requirements [1] - Ongoing projects in the pipeline are still in the R&D phase, with limited revenue from technical services, leading to a smaller overall revenue scale [1] - The company is optimizing costs and expenses while focusing on promising projects, such as the BC006 monoclonal antibody injection, which is nearing completion of Phase I clinical trials [1] Inventory Management - The company has upgraded its inventory management system, utilizing a BI intelligent analysis system to enhance efficiency [2] - A scientific "finished product inventory standard model" has been established to balance market demand dynamics and cost control [2] - The overall inventory level has improved significantly, maintaining a healthy inventory cycle of 1.5 to 2 months, which supports operational quality and cost optimization [2] Dividend Policy - The company is committed to providing stable returns to investors and has maintained a consistent cash dividend policy since its listing [2] - For the 2024 annual equity distribution plan, the company proposes a cash dividend of 3.5 CNY per 10 shares, totaling 206 million CNY [2] - The company plans to continue its cash dividend policy in 2025, barring any special funding needs [2] Basic Drug Directory - The adjustment of the national essential drug directory is led by relevant government departments, and the company has not engaged in any application processes during this period [2] - The timeline for the announcement of the new essential drug directory remains uncertain, as it depends on the progress of the adjustment work by the authorities [2]

Group 1: Company Overview and Product Advantages - The company specializes in liquid cooling products with self-developed high-performance manufacturing processes, offering significant advantages in thermal conductivity and pressure resistance compared to traditional methods [1] - The liquid cooling technology is increasingly replacing traditional air cooling solutions, particularly in high-performance computing and AI servers, leading to a notable increase in the value of each server [2] - The company has no direct competitors due to its unique technological advantages and patent protections [2] Group 2: Business Growth and Financial Performance - Revenue from the lead frame products increased by 467.80% year-on-year in 2024, with a further 236.78% growth in Q1 2025 [2] - The company expects continued strong growth in this product line, driven by high market demand and positive customer feedback [3] Group 3: Product Development and Market Strategy - The company is transitioning its lead frame products towards higher integration levels, focusing on IGBT and SiC power module packaging materials to meet the demands of rapidly growing industries like electric vehicles and AI [3] - The Super SIM card project aims to enhance user experience in railway scenarios, relying on partnerships with domestic operators and railway departments for implementation [4] Group 4: Market Position and Competitive Landscape - The market for smart safety solutions, including railway safety barriers, is characterized by high entry barriers and limited competition, positioning the company favorably for growth [5] - The company is actively promoting its smart safety projects, leveraging its advanced technology to meet the increasing safety demands of expanding high-speed rail networks [5] Group 5: Future Business Structure and R&D Investment - The company plans to optimize its product structure towards high-growth, high-tech value-added areas, with liquid cooling and packaging materials expected to become significant revenue sources [6] - R&D investment will remain a priority, with a focus on maintaining a balance between foundational research and core technology development [10] Group 6: Financial Health and Risk Management - The company reported a net profit of 11.57 million yuan in 2024, a 29.77% increase from the previous year, driven by improved product structure and cost management [11] - The company maintains a healthy accounts receivable turnover, with a focus on managing credit risk as it expands into new markets [11]

Group 1: Revenue Growth and Performance - The company's revenue growth in 2024 and Q1 2025 is primarily driven by product structure optimization and increased value per vehicle [1] - Profit growth is attributed to effective cost control, leading to a decrease in expense ratio relative to revenue [2] - The company maintains a strong outlook for sustainable growth, focusing on smart and electric technology routes [2] Group 2: Production and Technology Development - The company has solid technical reserves in steer-by-wire technology and is progressing with several mainstream automakers, with some projects expected to be mass-produced by 2026 [2] - The steering industry is undergoing a competitive restructuring due to the acceleration of vehicle electrification and intelligence [2] - The company plans to enhance R&D investment to strengthen its position in the smart steering sector [2] Group 3: Market Expansion and Client Base - The company is actively expanding its international market presence and is in the process of qualification certification with several well-known international automakers [2] - Major clients in the passenger vehicle sector include traditional automakers like Chery and Geely, as well as new players like NIO and Li Auto [3] - The company is optimistic about revenue growth in 2025, driven by increasing penetration of new energy vehicles and demand for intelligent steering systems [3] Group 4: Future Product Launches and Collaborations - New production capacity in 2025 will focus on electric steering columns and R-EPS [3] - The company is engaged in technical exchanges for steering technology with various clients in the unmanned logistics vehicle sector [3] - The company has developed technology reserves in rear-wheel steering, with projects expected to be mass-produced by 2026 [3]

Sales Performance - The sales of growth hormone have maintained steady growth in Q1 2025, with ongoing academic promotion efforts aimed at achieving recovery growth [1] - The sales revenue of Trastuzumab exceeded 100 million CNY in 2024, with a continuous upward trend since its launch, and significant growth expected in 2025 [1] Clinical Development - The HuA21 injection, targeting HER2, has completed the enrollment of subjects for Phase Ib/II clinical studies and plans to initiate Phase III trials based on mid-term analysis results [2] - The company is actively constructing production lines compliant with FDA and EU certifications, with ongoing validation and data organization for international market commercialization [2] mRNA Drug Development - The company is collaborating with Hefei Afana to develop mRNA drugs, specifically the AFN0328 injection for treating HPV-related cancers, currently in Phase I clinical trials [2] Oncolytic Virus Therapy - The company’s partner, Yuansong Biotech, has received clinical trial approval for the recombinant L-IFN adenovirus injection (YSCH-01), which is currently undergoing Phase I-IIa trials for advanced solid tumors [4]

Group 1: Company Overview and Market Position - Guangdong Qide New Materials Co., Ltd. focuses on carbon fiber products for the new energy vehicle industry, emphasizing lightweight and high-end applications [2] - The company provides a one-stop service for automotive-grade carbon fiber products, including structural design, material development, and mass production [2][3] Group 2: Technological Advancements and R&D - The company addresses high costs and low production efficiency in the carbon fiber industry through continuous technological upgrades and R&D investments [3] - Future innovations will focus on rapid curing, thermoplastic carbon fiber products, and integrated multi-process molding [3] Group 3: Expansion Plans - The company plans to expand carbon fiber production capacity through facility expansion, equipment investment, and personnel recruitment to meet increasing customer demand [4] - In Thailand, the company aims to enhance its production capabilities by establishing an intelligent production line to support local supply chain needs [5] Group 4: Strategic Planning - The company is strategically positioned to capitalize on the domestic industry's transformation and the high-end, lightweight development of new energy vehicles [6] - By 2024, the company aims to achieve mass production of high-performance lightweight automotive carbon fiber products and expand its overseas market presence [6] Group 5: Core Product Lines and Market Focus - The company will continue to focus on three core product lines: high-performance modified plastics, precision molded products, and high-performance carbon fiber products [7] - The goal is to become a global leader in new material solutions, leveraging opportunities in emerging fields such as flying cars and robotics [7]

Group 1: Business Overview - The company operates in three main business segments: adhesives and specialty resins, electronic information materials, and electronic technology [2] - The adhesive segment is a major revenue source, particularly in the wind power blade materials sector, with a comprehensive supply system established [2][3] Group 2: Market Performance - In 2024, the total sales volume of wind power epoxy structural adhesives and infusion resins reached nearly 10,000 tons [2] - The company maintains a leading market share in wind power structural adhesives as of Q1 2025 [2] Group 3: International Expansion - The company is expanding its overseas market presence, with certifications completed for products under LM Windpower and GE [4] - A new adhesive materials production base is being established in Thailand to better serve international clients [4] Group 4: Subsidiary Developments - Saiying Technology focuses on microwave technology and has developed products for radar and communication systems, with a shift towards civilian applications [5] - The company’s subsidiary, Dalian Qihua, specializes in high-quality epoxy resins, with an annual production capacity of 80,000 tons planned for expansion [6] Group 5: Production Capacity and Projects - The Fujian production base has entered formal production, with capacity to be gradually released based on market conditions [6] - The Tangshan production project is in the acceptance phase, with trial operations and formal production to follow [6]

Group 1: Cost Management - The company's pig farming cost has been decreasing monthly, reaching approximately 12.2 RMB/kg in May, a decrease of nearly 0.2 RMB/kg compared to the previous month, primarily due to improved production performance [3] - The company aims to achieve a cost target of 12 RMB/kg for the year through technological innovation and refined management in areas such as health management, breeding, nutrition formulation, and intelligent applications [4] Group 2: International Expansion - The global pig farming industry presents development opportunities, and the company is actively exploring overseas markets while deepening its domestic business [5] - The company is in the initial stages of internationalization and plans to conduct thorough research on overseas market demands and industry developments to inform future expansion strategies [5] Group 3: Debt Reduction Strategy - In 2024, the company will experience its first year where capital expenditures are less than asset depreciation, marking a key turning point in its development phase [6] - The company plans to gradually reduce total debt and the debt-to-asset ratio, improving its financial structure to maintain healthier financial indicators [6] Group 4: Dividend Policy - The company has entered a stable development phase with improving cash flow, which supports an increase in the dividend payout ratio [7] - From 2024 to 2026, the company will adjust the cash distribution of profits from no less than 20% to 40% of the distributable profits, with a total cash dividend of 7.588 billion RMB planned for 2024, setting a new annual dividend scale record [7] Group 5: Meat Processing Business Outlook - Since 2019, the company has developed its meat processing business, achieving an annual capacity of 29 million heads, with no plans for additional capacity [8] - The company aims to enhance overall capacity utilization through sales channel expansion and improve product structure to increase the proportion of processed products, thereby enhancing profitability [9] - The company will leverage synergies between its slaughtering and breeding operations to better understand market demands and improve breeding and production management based on consumer needs [9]